XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues $ 596.2 $ 512.4
Operating expenses:    
Salaries and benefits 178.9 151.7
Supplies 171.6 147.3
Professional and medical fees 63.6 55.5
Lease expense 20.0 22.8
Other operating expenses 37.3 31.6
Cost of revenues 471.4 408.9
General and administrative expenses 29.5 26.8
Depreciation and amortization 27.4 25.7
Transaction and integration costs 7.1 5.3
Grant funds (1.2) (15.1)
Gain on disposals and deconsolidations, net (0.1) (0.9)
Equity in earnings of unconsolidated affiliates (3.1) (2.6)
Litigation settlement (32.8) 0.0
Other income, net (2.4) 0.0
Total operating expenses 495.8 448.1
Operating income 100.4 64.3
Interest expense, net (56.3) (53.3)
Income before income taxes 44.1 11.0
Income tax expense (1.3) (0.2)
Net income 42.8 10.8
Less: Net income attributable to non-controlling interests (30.6) (31.8)
Net income (loss) attributable to Surgery Partners, Inc. 12.2 (21.0)
Less: Amounts attributable to participating securities 0.0 (10.3)
Net income (loss) attributable to common stockholders $ 12.2 $ (31.3)
Net income (loss) per share attributable to common stockholders    
Basic (in USD per share) $ 0.14 $ (0.57)
Diluted (in USD per share) [1] $ 0.14 $ (0.57)
Weighted average common shares outstanding    
Basic (shares) 87,995 54,773
Diluted (shares) [1] 90,272 54,773
[1] The impact of potentially dilutive securities for the three months ended March 31, 2021 was not considered because the effect would be anti-dilutive.